Page last updated: 2024-08-25

bleomycetin and ER-Negative PR-Negative HER2-Negative Breast Cancer

bleomycetin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Disney, MD; Li, Y	1

Other Studies

1 other study(ies) available for bleomycetin and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype. ACS chemical biology, 2018, 11-16, Volume: 13, Issue:11 Topics: Apoptosis; Base Sequence; Benzimidazoles; Binding Sites; Bleomycin; Cell Line, Tumor; DNA; Forkhead Box Protein O1; Humans; MicroRNAs; Molecular Structure; Phenotype; Piperazines; Triple Negative Breast Neoplasms	2018

Article

Year

Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.

ACS chemical biology, 2018, 11-16, Volume: 13, Issue:11

Topics: Apoptosis; Base Sequence; Benzimidazoles; Binding Sites; Bleomycin; Cell Line, Tumor; DNA; Forkhead Box Protein O1; Humans; MicroRNAs; Molecular Structure; Phenotype; Piperazines; Triple Negative Breast Neoplasms

2018